Hongping Xia

13PUBLICATIONS
20CO-AUTHORS
Haematological tumoursMicro- and nanosystemsGene and molecular therapyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 13, 2026
STK39 promotes the evolution cascade of hepatocellular carcinoma by facilitating PKR/NF-κB-mediated macrophage inflammatory response.

|Mar 10, 2026
Nature-inspired confined cascade enzyme nanoreactors for targeted atherosclerosis therapy.

Yuehuang Wu, Hongping Xia, He Ding

|Dec 02, 2022
Efficiently targeted therapy of glioblastoma xenograft via multifunctional biomimetic nanodrugs.

Zhipeng Yao, Xiaochun Jiang, Hong Yao

|May 25, 2022
Prognostic Perspectives of STING and PD-L1 Expression and Correlation with the Prognosis of Epstein-Barr Virus-Associated Gastric Cancers.

Qi Sun, Yao Fu, Xiaobing Chen

|Mar 17, 2022
The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.

Cunjie Chang, Muthukumar Rajasekaran, Yiting Qiao

|Dec 03, 2021
Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways.

Hongjin Chen, Fubing Wu, Haojun Xu

Pageof 3

Frequent Collaborators

2 joint publications

Kam Man Hui

1 joint publications

Guoren Zhou

1 joint publications

Cunjie Chang

1 joint publications

Yu Wang